Total Hip Arthroplasty Outcomes With Regional and Multimodal Analgesia

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

117 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-04-30

Study Completion Date

2014-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this retrospective chart review is to evaluate if the implementation of lumbar plexus block placement for postoperative pain and administration of multimodal oral analgesia have improved conditions in the postoperative period for patients undergoing total hip arthroplasty when compared to the placement of epidurals for postoperative pain management.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pain Management Following Total Hip Arthroplasty

NCT02568995

Postoperative Pain Intensity Rescue Pain Requirements

COMPLETED PHASE3

Postoperative Analgesia After Total Hip Replacement

NCT00219921

Total Hip Replacement

COMPLETED PHASE3

Intraarticular Analgesia After Total Hip Arthroplasty, a Randomised Study

NCT00289419

Arthroplasty, Replacement, Hip

COMPLETED PHASE4

The Analgesic Efficacy of Periarticular Infiltration of Local Anaesthetic for Total Hip Replacement

NCT01312077

Total Hip Arthroplasty

UNKNOWN PHASE4

Postoperative Pain Relief Following Total Hip Arthroplasty. A Comparison Between Intrathecal Morphine (IM) and Local Infiltration Analgesia (LIA)

NCT01281891

Primary Osteoarthritis Requiring Total Hip Replacement

UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary outcome: 48 hour opiate consumption in patients following THA. ' Secondary outcome: Time to first ambulation, assitstance needed with ambulation, opiate and regional related side effects, time to discharge orders.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arthroplasty Replacement, Hip Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lumbar plexus

Patients received a preoperative lumbar plexus nerve block (20 ml, ropivacaine 0.5%) for postoperative pain management with one to four multimodal oral pain medications (acetaminophen, celecoxib, oxycodone ER, gabapentin, pregabalin) administered preoperatively or in the first 48 hours postoperatively.

No interventions assigned to this group

Lumbar Epidural

Patients received a lumbar epidural preoperatively for postoperative pain management. Epidural infusions of ropivacaine 0.2% were initiated intraoperatively, administered until the morning of postoperative day 1, and titrated to patient comfort.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Primary total hip arthroplasty, (identified by current procedural terminology (CPT) code 27130) and
2. Either a) Epidural or b) Lumbar plexus peripheral nerve block with the administration of multimodal medication after July 2012.

\-